knowledge -WSS

knowledge

author：hotspot 2025-08-25 07:27:18 - browse：4111

A colorful illustrated montage of money, people in suits, and pills – business, politics and policy coverage from STAT — Mike Reddy for STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletterfollowing the flow of money in medicine. Sign upto get it in your inbox every Monday.

We did something a little different for this issue: We wanted to share some of the stories that explain the machinations of the U.S. health care system — stories that really influenced how we think about and report on this industry. Drop us a line to let us know which stories have resonated with you over the years: [email protected] and [email protected].

‘It’s The Prices, Stupid’

Everyone’s first major encounter with the health care system usually results in surprise and confusion. Whether it’s childbirth, caring for a family member, or dealing with one’s own injury or illness, a bill inevitably comes in the mail leaving most people asking, “Why does everything cost so much?” The answer invariably comes back to a popular 2003 journal article from a quartet of health economists titled, “It’s The Prices, Stupid.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Latigo launches with $135 million for Vertex

WSS

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Congress considering partial increase for doctor pay in Medicare

Do masks work? RCTs can't tell us

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Gene therapy has helped boys walk. Can scientists keep it that way?

Here’s what’s in the FDA plan to include pregnant women in clinical trials

leisure time

knowledge

‘It’s The Prices, Stupid’

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Medicare details structure of new drug price negotiation program

Paxlovid study fails to answer questions over benefit for broader groups

Moonlake's readout produced a cash windfall. Risks remain

Weight bias in eating disorder treatment complicated by new weight loss drugs

Alkermes shareholders re

Why are elite athletes different? Take a look at their microbes

Psychedelics group wrestles with new pharma identity

Death of patient in Alzheimer’s trial raises question of possible risks

Jerome Adams on the need for new antivirals for Covid

Why we need to separate burnout from moral injury in health care

Wikipedia

CDC concerned about possible undetected monkeypox spread in U.K.

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Congress must protect the remaining independent doctors

Websites selling Wegovy, Zepbound ingredients targeted by FDA

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

The battle over the Brookhaven Landfill on Long Island

hotspot

hotspot

explore

hotspot